SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
03-Jun-22 6:45 PM View: | Szot Matthew K Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 14,474 | $0.95 | $13,750.30 | 59% 24.7K to 39.17K | |
03-Jun-22 6:30 PM View: | Doody Kevin Medical Director Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Purchase | 177,306 | $0.95 | $168,441.00 | (100%) 177.31K to 0 | |
03-Jun-22 6:45 PM View: | Messina Rebecca Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 9,868 | $0.95 | $9,374.60 | 75% 13.18K to 23.05K | |
03-Jun-22 6:45 PM View: | Goren Andrea Chief Financial Officer | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 52,632 | $0.95 | $50,000.40 | 69% 76.38K to 129.01K | |
03-Jun-22 6:45 PM View: | Ryan Barbara Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 10,526 | $0.95 | $9,999.70 | 84% 12.46K to 22.99K | |
03-Jun-22 6:45 PM View: | Shum Steve Chief Executive Officer Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 58,885 | $0.95 | $55,940.80 | 85% 69.53K to 128.42K | |
03-Jun-22 6:45 PM View: | Davis Trent D Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 11,184 | $0.95 | $10,624.80 | 50% 22.44K to 33.62K | |
03-Jun-22 6:45 PM View: | Campbell Michael Jos. Chief Operating Officer Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 10,526 | $0.95 | $9,999.70 | 16% 65.24K to 75.76K | |
03-Jun-22 6:45 PM View: | Segal Jeffrey Director | Invo Bioscience, Inc. (INVO) | 01-Jun-22 | Private Purchase | 9,211 | $0.95 | $8,750.45 | 48% 19.01K to 28.22K | |
18-Jan-22 9:29 PM View: | Doody Kevin Medical Director Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 7,480 | -- | -- | 4% 169.83K to 177.31K | |
18-Jan-22 9:27 PM View: | Shum Steve Chief Executive Officer Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 20,111 | -- | -- | 32% 61.92K to 82.03K | |
18-Jan-22 9:27 PM View: | Messina Rebecca Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 8,311 | -- | -- | 171% 4.87K to 13.18K | |
18-Jan-22 9:26 PM View: | Ryan Barbara Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 8,588 | -- | -- | 69% 12.46K to 21.05K | |
18-Jan-22 9:30 PM View: | Davis Trent D Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 8,865 | -- | -- | 65% 13.57K to 22.44K | |
18-Jan-22 9:28 PM View: | Campbell Michael Jos. Chief Operating Officer Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 15,236 | -- | -- | 30% 50.0K to 65.24K | |
18-Jan-22 9:29 PM View: | Segal Jeffrey Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 8,034 | -- | -- | 81% 9.97K to 18.01K | |
18-Jan-22 9:26 PM View: | Goren Andrea Chief Financial Officer | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 5,361 | -- | -- | 6% 93.88K to 99.24K | |
18-Jan-22 9:27 PM View: | Szot Matthew K Director | Invo Bioscience, Inc. (INVO) | 15-Jan-22 | Grant | 10,250 | -- | -- | 71% 14.45K to 24.7K | |
07-Oct-21 4:57 PM View: | Goren Andrea Chief Financial Officer | Invo Bioscience, Inc. (INVO) | 05-Oct-21 | Market Purchase Duplicate | 30,674 | $3.26 | $99,997.20 | 60% 50.71K to 81.38K | 1% |
07-Oct-21 4:57 PM View: | Shum Steve Chief Executive Officer Director | Invo Bioscience, Inc. (INVO) | 05-Oct-21 | Market Purchase | 30,674 | $3.26 | $99,997.20 | 98% 31.25K to 61.92K | 1% |
13-May-21 9:10 PM View: | Messina Rebecca Director | Invo Bioscience, Inc. (INVO) | 11-May-21 | Grant | 4,806 | -- | -- | 100% 0 to 4.81K | |
12-May-21 4:09 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 10-May-21 | Market Purchase | 1,000 | $3.76 | $3,760.00 | < 1% 1.16M to 1.16M | (12%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 06-May-21 | Market Purchase | 1,000 | $3.85 | $3,848.40 | < 1% 3.46M to 3.46M | (14%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 04-May-21 | Market Purchase | 2,922 | $3.85 | $11,249.70 | < 1% 3.45M to 3.46M | (14%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 27-Apr-21 | Market Purchase | 3,800 | $4.44 | $16,870.10 | < 1% 3.45M to 3.45M | (26%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 20-Apr-21 | Market Purchase | 3,500 | $3.90 | $13,647.20 | < 1% 3.44M to 3.45M | (16%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 19-Apr-21 | Market Purchase | 5,801 | $3.64 | $21,109.80 | < 1% 3.44M to 3.44M | (10%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 16-Apr-21 | Market Purchase | 9,001 | $3.83 | $34,463.00 | < 1% 3.42M to 3.43M | (14%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 15-Apr-21 | Market Purchase | 322 | $3.85 | $1,239.18 | < 1% 3.42M to 3.42M | (14%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 14-Apr-21 | Market Purchase | 17,152 | $3.95 | $67,704.10 | < 1% 3.4M to 3.42M | (17%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 13-Apr-21 | Market Purchase | 5,800 | $3.97 | $23,039.90 | < 1% 3.4M to 3.4M | (17%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 12-Apr-21 | Market Purchase | 13,146 | $4.00 | $52,587.90 | < 1% 3.38M to 3.4M | (18%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 09-Apr-21 | Market Purchase | 27,811 | $4.08 | $113,472.00 | < 1% 3.36M to 3.38M | (19%) |
11-May-21 5:04 PM View: | Awm Investment Company, Inc. 10% Owner | Invo Bioscience, Inc. (INVO) | 08-Apr-21 | Market Purchase | 15,000 | $4.08 | $61,257.00 | < 1% 3.34M to 3.36M | (19%) |
05-Jan-21 8:02 PM View: | Davis Trent D Director | Invo Bioscience, Inc. (INVO) | 31-Dec-20 | Grant | 10,475 | -- | -- | 338% 3.1K to 13.57K | |
05-Jan-21 8:08 PM View: | Segal Jeffrey Director | Invo Bioscience, Inc. (INVO) | 31-Dec-20 | Grant | 8,838 | -- | -- | 777% 1.14K to 9.97K | |
05-Jan-21 8:11 PM View: | Szot Matthew K Director | Invo Bioscience, Inc. (INVO) | 31-Dec-20 | Grant | 12,112 | -- | -- | 518% 2.34K to 14.45K | |
05-Jan-21 8:04 PM View: | Doody Kevin Medical Director Director | Invo Bioscience, Inc. (INVO) | 31-Dec-20 | Grant | 8,184 | -- | -- | 5% 161.64K to 169.82K | |
05-Jan-21 8:05 PM View: | Ryan Barbara Director | Invo Bioscience, Inc. (INVO) | 31-Dec-20 | Grant | 10,148 | -- | -- | 438% 2.32K to 12.46K | |
01-Dec-20 5:32 PM View: | Szot Matthew K Director | Invo Bioscience, Inc. (INVO) | 27-Nov-20 | Grant | 2,339 | -- | -- | 100% 0 to 2.34K | |
01-Dec-20 5:30 PM View: | Ryan Barbara Director | Invo Bioscience, Inc. (INVO) | 27-Nov-20 | Grant | 2,317 | -- | -- | 100% 0 to 2.32K | |
01-Dec-20 5:30 PM View: | Segal Jeffrey Director | Invo Bioscience, Inc. (INVO) | 27-Nov-20 | Grant | 1,137 | -- | -- | 100% 0 to 1.14K | |
21-Jan-20 8:29 PM View: | Campbell Michael Jos. Chief Operating Officer Director | Invo Bioscience, Inc. (INVO) | 17-Jan-20 | Grant | 1,000,000 | -- | -- | 165% 607.8K to 1.61M | |
18-Oct-19 7:23 PM View: | Shum Steve Chief Executive Officer Director | Invo Bioscience, Inc. (INVO) | 16-Oct-19 | Grant | 400,000 | -- | -- | 67% 600.0K to 1000.0K | |
03-Dec-18 12:58 PM View: | Ranoux Claude 10% Owner | Invo Bioscience, Inc. (INVO) | 03-Dec-18 | Disposition Duplicate | 1,000,000 | $0.00 | $100.00 | (4%) 26.19M to 25.19M | |
01-Feb-19 10:00 PM View: | Ranoux Claude 10% Owner | Invo Bioscience, Inc. (INVO) | 03-Dec-18 | Disposition | 1,000,000 | $0.00 | $100.00 | (4%) 26.19M to 25.19M | |
03-Dec-18 12:58 PM View: | Ranoux Claude 10% Owner | Invo Bioscience, Inc. (INVO) | 03-Dec-18 | Sale | 500,000 | $0.05 | $25,000.00 | (2%) 25.19M to 24.69M | |
01-Feb-19 10:00 PM View: | Ranoux Claude 10% Owner | Invo Bioscience, Inc. (INVO) | 03-Dec-18 | Sale Duplicate | 500,000 | $0.05 | $25,000.00 | (2%) 25.19M to 24.69M | |
02-Nov-18 5:13 PM View: | Bowdring Robert Joseph Jr Director | Invo Bioscience, Inc. (INVO) | 31-Oct-18 | Grant | 1,015,940 | $0.39 | $396,217.00 | 9% 10.7M to 11.72M | (78%) |
02-Nov-18 5:22 PM View: | Shum Steve Director | Invo Bioscience, Inc. (INVO) | 31-Oct-18 | Grant | 400,000 | $0.39 | $156,000.00 | 200% 200.0K to 600.0K | (78%) |